A multicentre, randomised, controlled, double-blind study, evaluating the efficacy and safety of anakinra in chondrocalcinosis (Etude multicentrique randomisee controlee en double-aveugle contre placebo, evaluant l'efficacite et la securite de l'anakinra dans la crise de chondrocalcinose articulaire).

Next Previous
Trial Profile

A multicentre, randomised, controlled, double-blind study, evaluating the efficacy and safety of anakinra in chondrocalcinosis (Etude multicentrique randomisee controlee en double-aveugle contre placebo, evaluant l'efficacite et la securite de l'anakinra dans la crise de chondrocalcinose articulaire).

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Anakinra (Primary) ; Prednisolone
  • Indications Chondrocalcinosis
  • Focus Therapeutic Use
  • Acronyms APAC

    • Most Recent Events

    • 24 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top